低密度脂蛋白受體相關(guān)蛋白1(LRP1)單克隆抗體
Monoclonal Antibody to Low Density Lipoprotein Receptor Related Protein 1 (LRP1)
CD91; LRP; A2MR; APOER; APR; TGFBR5; Alpha-2-Macroglobulin Receptor; Prolow-density lipoprotein receptor-related protein 1; Apolipoprotein E receptor
- 編號(hào)MAB010Hu24
- 物種Homo sapiens (Human，人)相同的名稱(chēng)，不同的物種。
- 來(lái)源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號(hào))D9
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 免疫原RPB010Hu01-低密度脂蛋白受體相關(guān)蛋白1(LRP1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4）
- 性狀液體
- 濃度1mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應(yīng)用WB
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格20μl100μl200μl1ml10ml
- 價(jià)格¥ 635¥ 1483¥ 2118¥ 5295¥ 21180
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Western Blot; Samples: Lane1: Rat Liver lysate; Lane2: Rat Cerebrum lysate; Primary Ab: 2μg/ml Mouse Anti-Human LRP1 Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)LRP1的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別LRP1。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB010Hu01 | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB010Hu02 | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB010Hu01 | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)多克隆抗體 | WB; IHC |
| MAB010Hu21 | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)單克隆抗體 | WB |
| MAB010Hu23 | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)單克隆抗體 | WB |
| MAB010Hu22 | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)單克隆抗體 | WB |
| MAB010Hu24 | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)單克隆抗體 | WB |
| FAB010Hu02 | 抗低密度脂蛋白受體相關(guān)蛋白1(LRP1)單克隆抗體 | FCM |
| FAB010Hu04 | 抗低密度脂蛋白受體相關(guān)蛋白1(LRP1)單克隆抗體 | FCM |
| SEB010Hu | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB010Hu | 低密度脂蛋白受體相關(guān)蛋白1(LRP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| European Journal of Vascular and Endovascular Surgery | Plasma Low-density Lipoprotein Receptor-related Protein 1 Concentration is not Associated with Human Abdominal Aortic Aneurysm Presence[Science: Article] |
| Int J Cardiol | Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: A new potential biomarker for atherosclerosis[PubMed: 26285183] |
| International Journal of Cardiology | Circulating levels of soluble low-density lipoprotein receptor-related protein 1 (sLRP1) as novel biomarker of epicardial adipose tissue[pubmed:27543712] |
| Journal of Cellular and Molecular Medicine | Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy[doi:10.1111] |
| Scientific Reports | Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus[Pubmed:29348672] |
| Atherosclerosis | Soluble low-density lipoprotein receptor-related protein 1 as a biomarker of coronary risk: Predictive capacity and association with clinical events[] |
| Biomedical Reports | Gender difference and genetic variance in lipoprotein receptor?related protein 1 is associated with mortality[] |
| biorxiv. | CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling[] |
| JCI Insight | CMTM6 drives cisplatin resistance by regulating Wnt signaling through ENO-1/AKT/GSK3|? axis[33434185] |